Dr. Weerawan Rod-in | Biotechnology Awards | Best Researcher Award

Dr. Weerawan Rod-in | Biotechnology Awards | Best Researcher Award

Dr. Weerawan Rod-in, Naresuan University, Thailand

Weerawan Rod-In is a researcher with a Ph.D. in Applied Marine Biotechnology and Engineering from Gangneung-Wonju National University, Korea, and an M.S. in Agricultural Biotechnology from Naresuan University, Thailand. Specializing in marine biotechnology, immunology, and bioactive compounds, Weerawan has authored 33 Scopus-indexed publications, holds an h-index of 9, and has garnered 227 citations. She has actively participated in international conferences and received awards for her thesis and poster presentations. Her research is particularly focused on the immunostimulatory effects of natural marine extracts and polysaccharides.

Professional Profile:

Scopus

Suitability for Best Researcher Awards: Weerawan Rod-In

Summary of Suitability:

Dr. Weerawan Rod-In has demonstrated a remarkable research career, making her a strong candidate for a Best Researcher Award. She has earned a Ph.D. in Applied Marine Biotechnology and Engineering from Gangneung-Wonju National University, South Korea, and an M.S. in Agricultural Biotechnology from Naresuan University, Thailand. Her educational background showcases her deep understanding of marine and plant biotechnology, as well as agricultural sciences, which positions her in interdisciplinary fields crucial for modern research.

🎓Education:

Weerawan Rod-In earned her Ph.D. in Applied Marine Biotechnology and Engineering from Gangneung-Wonju National University, Gangwon, Korea, where she studied from 2017 to 2021. Prior to this, she completed her M.S. in Agricultural Biotechnology at Naresuan University in Phitsanulok, Thailand, from 2012 to 2015. She also holds a B.S. in Biotechnology, with a specialization in Plant Biotechnology, from Naresuan University, where she studied from 2008 to 2012.

🏢Work Experience:

Weerawan Rod-In has made significant contributions to the field of marine biotechnology, with a strong focus on immunology and bioactive compounds. Her research involves exploring the immunostimulatory properties of marine extracts and the therapeutic potential of polysaccharides. She has authored 33 research publications in prestigious journals and has actively engaged in international conferences and workshops, showcasing her expertise and commitment to advancing knowledge in marine biotechnology.

🏅Awards:

Weerawan Rod-In has been recognized for her outstanding academic contributions, receiving the Thesis Presentation Encouragement Award at the 2020 International Symposium & Annual Meeting of the Korean Society of Food Science and Nutrition (KFN) in Jeju, Korea. Additionally, she was honored with the Excellent Poster Presentation Award at the 2019 Annual Spring Conference of the Korean Society for Horticultural Science, held in Gyeongju, Korea. These accolades highlight her dedication and excellence in research presentation and innovation.

Publication Top Notes:

  • Title: In vitro immune-enhancing effects of Platycodon grandiflorum combined with Salvia plebeian via MAPK and NF-κB signaling in RAW264.7 cells

    Citations: 1

  • Title: Inhibitory effects of Oncorhynchus mykiss lipids in LPS-induced RAW264.7 cells via suppression of NF-κB and MAPK pathways

    Citations: 2

  • Title: Inhibitory effects of polysaccharides from Korean ginseng berries on LPS-induced RAW264.7 macrophages

    Citations: 3

  • Title: In Vitro Anti-Inflammatory and Skin Protective Effects of Codium fragile Extract on Macrophages and Human Keratinocytes in Atopic Dermatitis
  • Title: Immune Enhancement Effects of Neutral Lipids, Glycolipids, Phospholipids from Halocynthia aurantium Tunic on RAW264.7 Macrophages

 

 

 

 

Dr. Priyanka Singh | Nanobiotechnology Awards | Most Cited Paper Award

Dr. Priyanka Singh | Nanobiotechnology Awards | Most Cited Paper Award

Dr. Priyanka Singh , Denmark Technical University , Denmark

Dr. Priyanka Singh is a Senior Researcher at the Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark. With over seven years of post-doctoral experience, she specializes in green nanoscience and medical biology, focusing on innovative drug development for cancer and infections. Dr. Singh holds a Ph.D. in Nanoscience from Kyung Hee University and has secured substantial external funding for her pioneering research in nanomaterials. She is also committed to mentoring Ph.D. students and fostering interdisciplinary collaborations to advance cell biology and translate research into impactful outcomes.

Professional Profile:

Google Scholar

Education:

Dr. Priyanka Singh earned her Ph.D. in Nanoscience from Kyung Hee University, South Korea, in 2016, where she designed nanoparticles and drug conjugates/nanoformulations to enhance the pharmacokinetics of poorly water-soluble drugs for cancer and infectious cells. She holds a Diploma in Transformational Leadership Programme-Leading Women from CBS, Denmark, completed in November 2020. Dr. Singh has acquired several certifications from the University of Wisconsin–Madison, USA, including physiological characterization, solubilization, and solid form screening for drugs (2022), biologics (2021), drug development processes and CMC aspects (2021), and preclinical and phase 1 oral drug formulations (2021). Additionally, she completed a Teaching Lab course at DTU in January 2022, focused on university-level teaching and learning. Her academic background also includes a Master’s in Microbiology from CSJMU, India (2008-2010), and a Bachelor’s in Microbiology from Kachchh University, India (2005-2008).

Work Experience:

Dr. Priyanka Singh is a Senior Researcher at the Center for Biosustainability, Technical University of Denmark, since December 2023. She leads studies on developing nanomaterials for anticancer and antimicrobial drugs, publishing in high-impact journals, and supervises Ph.D. students in hands-on development of these materials. She is also leading a project on “graphene-based solutions for marine biofilm inhibition” and employs advanced techniques like Flow cytometry, SEM, TEM, and Incucyte for characterizing nanomaterials in various disease models. From January 2021 to November 2023, as a Researcher at the same center, she led a team advancing nanomaterials in medical applications, focusing on biologics formation and characterization, investigating their impact on cancer cells, and enhancing their therapeutic potential.

Publication Top  Notes: